Read More Pharma Industry News Merck and Eisai announce major win as Welireg plus Lenvima delays progression in advanced renal cell carcinoma Find out how Merck and Eisai’s Welireg + Lenvima combo redefines kidney cancer care after immunotherapy and what this major Phase 3 win means for investors. bySoujanya RaviOctober 28, 2025